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Abstract
Background: Stimulation of C3H 10T1/2 murine fibroblasts with interferon-γ(IFN) and bacterial
lipopolysaccharide (LPS) generates reactive oxygen and nitrogen species leading to DNA damage,
lipid oxidation, and tocopherol oxidation. The tocopherols possess unique chemical and biological
properties that suggest they have important roles related to intracellular defense against radical-
mediated damage.
Results: Despite increased levels of reactive oxidants and decreased media tocopherol, cellular
levels of γ-tocopherol, but not α-tocopherol, were observed to increase significantly when cells
were treated with IFN/LPS. Inhibition of nitric oxide (NO) synthesis by a specific inhibitor of
inducible NO synthase (iNOS) increased both intracellular α-tocopherol and γ-tocopherol
concentrations, but did not significantly alter the reduction in media tocopherol levels caused by
IFN/LPS treatment. Both exposure to exogenous NO and cellular synthesis of NO in cell culture
increased media levels of 8-epi-prostaglandin F2α, a marker of oxidative lipid damage, whereas
inhibition of endogenous NO synthesis reduced media 8-epi-prostaglandin F2α formation to
control levels.
Conclusion: Elevated intracellular levels of γ-tocopherol in response to the cellular inflammatory
state may indicate that it serves a unique role in minimizing cellular damage resulting from
endogenous NO synthesis. Results of the current study suggest that NO is an important mediator
of damage within the cell, as well as in the oxidation of both α- and γ-tocopherols. The paradoxical
increase in cellular tocopherol associated with the induction of NO synthesis may indicate either
enhanced cellular transport/decreased export for tocopherols or recruitment of free tocopherol
from tocopherol storage molecules.
Background
Vitamin E, a term used to describe the family of related
tocopherol and tocotrienol species of widely varying bio-
activity, was discovered over eighty years ago by Evans and
Bishop [1]. The vitamin E bioactivity of tocopherols is
characterized by their ability to prevent certain reproduc-
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gility in mammals [2]. Dietary levels of vitamin E needed
to meet these essential functions are relatively modest, are
generally provided for from a balanced diet, and are prin-
cipally associated with α-tocopherol, the predominant
form of tocopherol found in plasma [2]. Recently, roles
for the tocopherols in human and animal health, beyond
those traditionally associated with vitamin E bioactivity,
have been identified from epidemiological, clinical and
basic laboratory research, suggesting that tocopherols may
modulate the development and progression of cardiovas-
cular disease [3,4], cancer [5,6] and neurological abnor-
malities [2,7], as well as affect immune function [8],
natriuresis [9], and inflammation [10]. These newly iden-
tified functions of the tocopherols appear un-related to
their vitamin E associated bioactivity, rather, it is observed
that subtle chemical differences in structure and/or func-
tion between the various tocopherols are responsible for
the different biological properties they manifest [11-13].
Indeed, these properties may be important in explaining
differential epidemiologic associations observed for α-
and γ-tocopherols with cancer incidence [6,14-16], and
suggest unique mechanisms for tocopherol function, dis-
tinct from those traditionally associated with vitamin E
bioactivity. These alternative tocopherol functions are
often observed at relatively elevated doses (20 – 100 µM)
in cell culture and include effects on cellular proliferation,
apoptosis, cellular adhesion, regulation of gene expres-
sion, inflammation, and cellular signaling [reviewed in
17, 18] that logically could have effects on many aging-
related diseases. However, the absence of definitive evi-
dence from human clinical trials that higher doses of toco-
pherols have beneficial long-term effects has precluded
dietary recommendations for either higher amounts of α-
tocopherol in the diet or the intake of other tocopherol
analogues [2].
While γ-tocopherol is the main tocopherol in the U.S.
diet, α-tocopherol predominates in human plasma,
approximately 30 µM for α-tocopherol vs 5 µM for the γ-
form [19]. It now appears that the relatively lower contri-
bution of γ-tocopherol to plasma total tocopherol is due
in part to its metabolism to form γ-carboxyethyl-hydroxy-
chroman, a compound with natriuretic [9] and anti-
inflammatory properties [10,20], as well as to its
enhanced uptake by cells [21,22]. Because of its metabo-
lism, it is more difficult to maintain plasma levels of γ-
tocopherol sufficient to meet vitamin E requirements,
however, if the metabolic pathway is blocked [23], plasma
γ-tocopherol levels rise and γ-tocopherol is then equiva-
lent to α-tocopherol in meeting the vitamin E require-
ment of rats [24]. The most recent dietary
recommendations have established 15 mg/day of d-α-
tocopherol as the requirement for humans, do not recog-
nize any contribution from γ-tocopherol with respect to
vitamin E bioactivity, and do not establish any minimum
requirement for γ-tocopherol, as no unequivocal long-
term or short-term need has been established [2]. While
the official recommendation is restricted to α-tocopherol,
based on currently accepted endpoints, it is unclear
whether α-tocopherol is able to fully substitute for the
potential functions of γ-tocopherol postulated from
observed differences in the chemical and biological effects
of the two analogues. However, in the case of human
natriuretic factor, it is clear that enzymatic generation of
the active metabolite preferentially occurs only with γ-
tocopherol.
Although both α- and γ-tocopherols are effective anti-oxi-
dants, each possesses unique chemical properties that
offer advantages depending on the nature of the oxidant
and the physical environment in which the oxidation
reaction takes place. In general, it appears that although α-
tocopherol is the predominant form responsible for
quenching oxygen radical damage [25-27], γ-tocopherol is
more effective against nucleophilic oxidants such as per-
oxynitrite [28] and nitrogen radicals such as NO2 [11,12].
In addition tocopherol oxidation products, such as toco-
pheryl quinones [29] and nitrite esters [11] have been
implicated as potential DNA damaging agents and long-
term exposure, even to small quantiies may limit the opti-
mal beneficial level of tocopherols in vivo [30].
Reactive nitrogen species have been implicated in the gen-
eration of cellular damage associated with chronic inflam-
mation [31]. NO, produced via the enzymatic conversion
of arginine to citrulline by inducible NO synthase (iNOS)
can easily oxidize to more reactive nitrogen species in the
lipid environment of the cell resulting in enhanced poten-
tial for DNA damage [32]. iNOS inhibitors [33] and γ-
tocopherol [11] have been shown to effectively block neo-
plastic transformation of C3H 10T1/2 cells in a standard
carcinogenesis assay. Epidemiologic and clinical studies
support a role for the tocopherols in the prevention of
cancer, especially for prostate cancer [5,6,16,34]. The role
of chronic inflammation, associated with cytokine and
oxidant generation has been generally implicated in the
process of cancer formation and progression [35] and NO
may be an important mediator, both positively and nega-
tively in this process.
α-Tocopherol is also known to enhance the immune
response of vertebrates [36-38], facilitating the elimina-
tion of infectious organisms [39,40]. The effect of α-toco-
pherol on immune function increases as a function of
serum tocopherol, well beyond levels necessary for opti-
mal vitamin E bioactivity, as defined by traditional bio-
assays for vitamin E activity and recommended levels of
dietary intake, suggesting a possible alternative mecha-
nism of action. One of the key cellular responses to an
invading pathogen is up-regulation of iNOS by many cell
types, including macrophages, resulting in significant gen-
eration of NO [41]. In rodent macrophages and fibrob-
lasts, this is often mediated by cytokines such asPage 2 of 12
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lipopolysaccharides (LPS) or viruses, and the subsequent
immune response is enhanced by α-tocopherol [42]. We
have shown previously that γ-tocopherol, but not α-toco-
pherol, enhances cytokine-mediated NO synthesis in C3H
10T1/2 cells [43] and that γ-tocopherol more effectively
protects against cell death in rat insulinoma cells stimu-
lated to produce NO by interleukin 1-β [12]. A specific
role for γ-tocopherol in immune function has not been
established, however. We hypothesize that γ-tocopherol
facilitates an enhanced immune response to infection by
reducing NO-mediated intracellular damage, through its
antioxidant effects, thereby allowing a greater oxidative
attack toward a pathogen by cells. Using C3H 10T1/2
murine fibroblasts treated with IFN/LPS as a model for a
cellular inflammatory response, we endeavored to deter-
mine the effect of endogenous NO formation on cellular
tocopherol levels, as well as oxidation products of toco-
pherols and other key cellular biomolecules formed in
cells and in the surrounding aqueous medium in an effort
to discern the nature of the reactions occurring in the cel-
lular environments in which the tocopherols function.
Results
Modulation of media and cellular tocopherol levels
Preliminary experiments designed to study simultaneous
uptake of alpha and gamma tocopherol analogues (5.0
µM each) indicated that tocopherol levels in C3H 10T1/2
cells were stable after seven days with re-treatment (Figure
1) and that no detectable levels of tocopherol were
present in the culture medium in the absence of exoge-
nous treatment. Loss in media tocopherol over this 14 day
period was 29.5% and 17.9% for alpha- and gamma-
tocopherols respectively. For both tocopherols peak cellu-
lar tocopherol levels were approximately 3–4% of the
total tocopherol initially available to cells indicating that
a significant fraction of α-tocopherol and γ-tocopherol
could not be accounted for in the combined media and
cellular analysis. It was also observed that cellular toco-
pherol levels increased as a function of external tocophe-
rol concentration over the range of 0–100 µM tocopherol
(data not shown).
Subsequent experiments exploring the role of oxidation in
tocopherol uptake and metabolism used a protocol in
which cells were pre-loaded with tocopherol for one week
prior to treatment with IFN/LPS in order to assure stable
cellular tocopherol levels. As shown in Figure 2A, cells
treated with a combination of α- and γ-tocopherols (10
µM each) and IFN/LPS showed a significant decrease in
media levels for both α- and γ-tocopherols relative to con-
trols of approximately 15% over a 7-day period. This
decrease in α- and γ-tocopherols in media was slightly,
but not significantly, reversed by simultaneous inhibition
of NO synthesis with 10 µM PBIT, a highly active and spe-
cific inhibitor of the iNOS protein. Treatment with PBIT
alone slightly increased the observed media tocopherol
levels over control values. In contrast, IFN/LPS treatment
caused significantly increased cellular γ-tocopherol levels
and slightly decreased α-tocopherol levels in cells (Figure
2B). PBIT treatment, however, enhanced intracellular lev-
els of α- and γ-tocopherols in both IFN/LPS-treated and
control cells (Figure 2B). This suggests that, in contrast to
media, NO may mediate intracellular oxidation of α-toco-
pherol and γ-tocopherol. As seen in Table 1, the ratio of γ-
/α-tocopherol is significantly elevated in cells relative to
controls for all treatment groups, particularly in those
treated with IFN/LPS alone. The observed change in ratio
is particularly significant in that one tocopherol serves as
an internal control for the other, and this ratio therefore is
independent of any potential measurement error affecting
the absolute values reported. Absolute values of α- and γ-
tocopherols increased in both media and cells when NO
production was blocked with PBIT, however, IFN/LPS
treatment alters the tocopherol ratio in cells in favor of γ-
tocopherol, independently of NO synthesis. Total recov-
ery of tocopherol (media + cells) ranged from a low of
61.3% for α-tocopherol in cells treated with IFN/LPS to a
high of 83.6% for γ-tocopherol in PBIT-treated cells
(Table 1).
Cellular uptake of tocopherols treated with a mixture of tocopherols in mediumFigure 1
Cellular uptake of tocopherols treated with a mixture of 
tocopherols in medium. Cells were grown to confluence and 
given a media change followed by tocopherol treatment (Day 
0). A second media change and tocopherol re-treatment was 
performed on Day 7. Tocopherols (α-,γ-; 5.0 µM each in eth-
anol) were measured in cells in triplicate and cell numbers 
for each treatment group determined as described under 
Methods for the extraction and analysis of tocopherols from 
cells and for cell counting. Data points represent the mean of 
three determinations ± SEM.Page 3 of 12
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To determine if induction of NO causes cellular lipid oxi-
dation, levels of nitrite and 8-epi-prostaglandin F2α (a
radical-mediated oxidation product of arachidonic acid)
were determined in media, as shown in Figure 3 in
response to IFN/LPS ± PBIT treatment. PBIT effectively
blocked both nitrite and 8-epi-prostaglandin F2α forma-
tion in confluent C3H 10T1/2 cells, consistent with NO-
mediated intracellular generation of isoprostane from ara-
chidonic acid and in agreement with the observed protec-
tive effect of PBIT on cellular tocopherol levels.
Combination treatment with alpha + gamma -tocophe-
rols significantly decreased basal isoprostane formation,
but enhanced the effect of IFN/LPS treatment (Figure 3).
To further demonstrate that NO mediates isoprostane for-
mation, the effect of increasing concentrations of sper-
mine nonoate (exogenous NO generator) on cellular
isoprostane formation was determined, both in the pres-
ence and absence of endogenous NO that was induced by
IFN/LPS treatment (Figure 4). Consistent with the data
shown in Figure 3, exogenous NO caused a progressive
increase in media isoprostane levels, for treatment levels
up to 30 µM spermine nonoate. Interestingly a corre-
sponding cytotoxic effect was noted at concentrations of
spermine nonoate above 30 µM. However, cells treated
with IFN/LPS or γ-tocopherol prior to spermine nonoate
treatment were somewhat protected from the toxic effects
of 30 µM spermine nonoate, despite the significantly
greater NO exposure for these cells (Figure 5). At levels
higher than 40 µM, spermine nonoate was toxic to all
treatment groups (data not shown).
Oxidation products of tocopherols in tissue culture
Among the tocopherols, γ-tocopherol is observed to react
preferentially with NO2 in a lipophilic model system such
that when a mixture of the 4 tocopherol analogues is
exposed to NO2, only γ-tocopherol reacts until it disap-
pears, followed by the subsequent destruction of the other
tocopherol analogues [44]. γ-Tocopherol has previously
been reported to react with NO2 to form two main oxida-
tion products (5-nitro-γ-tocopherol and the ortho-qui-
none, tocored) in vitro depending upon the polarity of the
reaction environment [12]. In a polar aqueous environ-
ment, 5-nitro-γ-tocopherol is formed preferentially,
whereas in a lipid phase environment, tocored is gener-
ated [12]. In order to determine the nature of tocopherol
reaction products formed in cells growing in culture after
IFN/LPS treatment, cultures containing either 10 µM α-
tocopherol or 10 µM γ-tocopherol were exposed to IFN/
LPS for 7 days and reaction products were determined.
IFN/LPS treatment significantly increased media and cel-
lular levels of α-tocopherol quinone (Table 2), however,
no significant increase in reaction products of γ-tocophe-
rol, including 5-nitro-γ-tocopherol, tocored, or γ-tocoph-
eryl-quinone was detected in media. However a 39%
increase in γ-tocopheryl-quinone in cells was noted (Table
2).
Although α-tocopherol levels dropped approximately
30% in IFN/LPS-treated cultures, no decrease in media γ-
tocopherol levels was seen relative to control cultures
(Table 2). This is in contrast to what was observed in Fig-
ure 1 when both α- and γ-tocopherols were present simul-
taneously and each decreased approximately 15% with
IFN/LPS treatment relative to controls. This suggests the
possibility of a reaction between an oxidized α-tocophe-
rol intermediate and γ-tocopherol in the media, poten-
tially sparing α-tocopherol at the expense of the γ-
analogue, analogous to the regeneration of α-tocopherol
from its radical intermediate by ascorbate [45]. Exposure
of tocopherol-containing cell cultures to the NO genera-
tor, SIN-1, destroyed > 90% of media tocopherol, yet did
not significantly alter tocopherol levels in cells after two
hours of exposure (Table 2). In γ-tocopherol-treated cell
cultures exposed to SIN-1, 5-nitro-γ-tocopherol was the
predominant product formed along with an unknown
compound co-eluting with tocored, whereas α-tocoph-
eryl-quinone predominated in α-tocopherol containing
Table 1: Percent recovery and the ratio of γ-/α-tocopherol in the media fraction and cellular fraction of cells treated with IFN/LPS and/
or PBIT as described in Figure 1. Values represent the mean of 6 determinations ± SEM.
Tocopherol Recovery# (%) Ratio (γ/α tocopherol)
Treatment Media Cells Total Media Cells Media vs Cells
*p Value
αT|γT αT|γT αT|γT
Control 72.8|73.5 2.79|3.26 75.6|76.8 1.01 ± 0.01 1.17 ± 0.04 0.002
IFN/LPS 58.5|60.4 2.83|4.43 61.3|64.8 1.03 ± 0.01 1.57** ± 0.01 < 0.0001
IFN/LPS + PBIT 63.1|62.7 5.22|7.45 68.3|70.2 1.00 ± 0.01 1.43** ± 0.02 < 0.0001
PBIT 76.5|78.4 4.10|5.24 80.6|83.6 1.02 ± 0.01 1.27 ± 0.02 < 0.0001
* Student t-test for difference between media and cells.
** ANOVA for differences between treatment groups of log transformed values p < 0.01 relative to control cells.
# Based on treatment of 100 nmoles of each tocopherol per culture dishPage 4 of 12
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NO synthesis and its effect on isoprostane formationFigure 3
NO synthesis and its effect on isoprostane formation. Con-
fluent cultures of C3H 10T1/2 cells were treated for seven 
days as indicated with a combination of 10 µM α-tocopherol 
and 10 µM γ-tocopherol or with 25 µL ethanol as a control 
in 35 mm culture dishes (5 ml total media volume per dish). 
The cell culture media was then changed and cultures were 
treated with PBS (control), IFN/LPS, and/or 10 µM PBIT as 
indicated ± tocopherols. After seven days, cell culture media 
was assayed for 8-epi-prostaglandin F2α (A) or nitrite (B) as 
described in Methods. Values reported represent the mean ± 
SEM (N = 9). * p < 0.01 relative to corresponding control 
(ANOVA analysis of log-transformed values). Tocopherol-
treated isoprostane levels are significantly different for each 
treatment group in comparison to non-tocopherol-treated 
cells (p < 0.01). Nitrite values between tocopherol-treated 
and control cells were not significantly different.
Effect of cellular NO synthesis on media and cellular levels of α- and γ-tocopherolsFigure 2
Effect of cellular NO synthesis on media and cellular levels of 
α- and γ-tocopherols. At confluence, a mixture of α-plus γ-
tocopherol in 50 µl ethanol (10 µM final concentration/100 
ng/dish for each tocopherol) was added to each 100 mm cul-
ture dish (10 mL of culture medium per dish). After seven 
days cell culture medium was changed and cells were re-
treated with tocopherols. At this time six of the 12 dishes 
were also treated with IFN (10 ng/ml) & LPS (1 µg/ml) to 
stimulate NO production. Three culture plates that were 
treated with IFN/LPS and three that contained only the mix-
ture of tocopherols, were also treated with 50 µl of 2 mM 
PBIT in PBS, yielding a final media concentration of 10 µM 
PBIT. The other 6 dishes were treated with either 50 µl PBS 
vehicle or 50 µl of 2 mM PBIT. Seven days later, media nitrite 
and 8-epi-prostaglandin F2α levels were measured as 
described in the methods section in duplicate. Tocopherol 
levels were measured in the cell culture medium (A) and in 
cells (B). Values represent the mean of six determinations ± 
SEM. * (p < 0.01) **(p < 0.05) Indicates significantly different 
from corresponding control value by ANOVA analysis. In 
addition all cellular γ-tocopherol levels were significantly 
higher than the corresponding α-tocopherol level for each 
treatment by student t-test (p < 0.01). PBIT treatment signif-
icantly elevated both α- and γ-tocopherols in IFN/LPS-
treated cells (p < 0.01 by ANOVA).
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which both α- and γ-tocopherols were simultaneously
present (Figure 2), cellular γ-tocopherol increased signifi-
cantly in cells in response to IFN/LPS treatment, whereas
α-tocopherol remained unchanged from control values
(Table 2).
Discussion
The cellular response to infection is well known to involve
oxidative attack by host cells on an invading organism.
While the corresponding inflammatory state promotes
clearance of the infection, it also is associated with cellular
damage to the host cells and increased risk for the subse-
quent development of cancer [35,46]. The precise mecha-
nism by which normal cells defend against the oxidative
assault they release is less clearly understood. The results
presented here suggest that host cellular defense responses
may be initiated by the sequence of events mimicking a
bacterial infection such that cells are protected to a greater
extent from the effects of nitrogen oxidants. While the
induction of NO synthesis is one key change that occurs
in this C3H 10T1/2 cell line in response to IFN/LPS expo-
sure, it appears that NO is responsible for only a small
fraction of the loss of extracellular tocopherol that ensues
(Figure 2). Presumably other oxidants are responsible for
the loss of tocopherol in the media and these oxidants
may preferentially react with α-tocopherol, as has been
shown previously for the reaction of α-tocopherol with
reactive oxygen species [25-27] and has been observed in
vitro where α-tocopherol appears to react preferentially
with extracellularly generated oxidants [47]. This would
be consistent with the observed formation of the oxidized
quinone form of the tocopherols and the absence of the
nitro derivatives of γ-tocopherol in the medium of IFN/
LPS-treated cells. The loss of γ-tocopherol in media only
in the presence of α-tocopherol (Figure 2 vs Table 2), sug-
gests that an interaction may occur between these two
molecules, possibly through the reaction of the α-tocoph-
eryl radical intermediate with γ-tocopherol, thereby
reducing the oxidative loss of α-tocopherol at the expense
of γ-tocopherol. When α-tocopherol alone was present in
the media, the relative loss of α-tocopherol was doubled,
yet when γ-tocopherol alone was present, no loss of toco-
pherol in the media was observed. It is interesting to note
that measurement of media tocopherol, cellular tocophe-
Effect of IFN/LPS treatment on the toxicity of spermine non-oateFigure 5
Effect of IFN/LPS treatment on the toxicity of spermine non-
oate. Cell counts on cultures treated as described in Figure 4 
were conducted utilizing a Coulter Counter (see Methods 
section). In addition one set of cell cultures was treated with 
30 µM γ-tocopherol. Data are reported as the mean # of 
cells per dish ± SEM (n = 6).
Formation of 8-epi-prostaglandin F2α by exogenous treat-ment of C3H 10T1/2 cells with spermine nonoateigure 4
Formation of 8-epi-prostaglandin F2α by exogenous treat-
ment of C3H 10T1/2 cells with spermine nonoate. Confluent 
cultures of C3H 10T1/2 cells were treated with either IFN/
LPS or PBS at the time of weekly media change. Aqueous 
spermine nonoate was then added to give the final indicated 
concentration. After one week, media samples were analyzed 
for 8-epi-prostaglandin F2α as described in the Methods sec-
tion. Values are reported as pg/ml 8-epi-prostaglandin F2α ± 
SEM (n = 6).Page 6 of 12
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approximately 70–80% of the original tocopherol with
which cells are treated. This is in agreement with the
results reported by Gao, et al. [22] in macrophages treated
with tocopherol, where approximately 26% of α-tocophe-
rol was unaccounted for either as tocopherol or its known
oxidation products. Gao et al. [22] also reported that γ-
tocopherol significantly enhanced uptake of α-tocopherol
in macrophages.
Despite the enhanced generation of oxidants when cells
are treated with IFN/LPS, cellular levels of γ-tocopherol
paradoxically increase significantly and α-tocopherol
remains constant or decreases only slightly. This is con-
sistent with the observations of Jiang et al [48], who, uti-
lizing a rat model of inflammation, observed no effect on
α-tocopherol and an increase in cellular and plasma γ-
tocopherol concentrations in vivo in response to inflam-
mation, along with a reduction in protein nitration with
γ-tocopherol supplementation. It is not clear what the
mechanism(s) responsible for increased levels of cellular
tocopherol resulting from IFN/LPS treatment may be. Pos-
sibilities include enhanced cellular uptake/decreased cel-
lular export, decreased degradation, or the conversion of
tocopherol from a storage form not observed in the anal-
ysis of free tocopherol. In the first case a transport system
would theoretically be required which could be controlled
in some manner to cause increased uptake of tocopherol
under inflammatory conditions or decreased cellular
excretion. From our studies we see no evidence for such a
selective uptake system, as cellular levels generally appear
correlated with external concentrations. The second possi-
bility, that degradation is decreased, would appear to be
counterintuitive given the increase in oxidation products
observed for both alpha and gamma tocopherols when
cells were treated with IFN/LPS, however, a mechanism
involving both increased transport of tocopherols into
cells and enhanced degradation of α-tocopherol would fit
with the experimental data. A third possibility to explain
the elevation of cellular tocopherol in response to inflam-
mation is that tocopherols may exist in storage forms. The
recent discovery of α-tocopheryl phosphate [49] provides
a potential candidate for such a storage system in cells.
Negis et al. [50] report that approximately 13% of α-toco-
pherol in rabbit serum exists as α-tocopheryl phosphate
and that it represents a more bioactive form of tocopherol.
Conversion of this form of tocopherol to the lipid soluble
form in response to IFN/LPS could explain the curious
increase in tocopherol observed under conditions of
increased oxidative stress and could conceivably be under
the control of a cellular phosphatase, however, it is not yet
known if γ-tocopherol forms such a molecule. Other pos-
sible storage forms could include esters such as the acetate
or glucoronides. It is also possible that intracellularly, α-
tocopherol spares γ-tocopherol by reacting with a γ-toco-
pheryl intermediate, however, this would not explain the
overall increase in γ-tocopherol observed, as cellular γ-
tocopherol levels increased similarly both in the presence
and absence of α-tocopherol (Figure 2 and Table 2). The
conditions utilized in the present study assess only the
steady state levels of tocopherols and their oxidation
products and, therefore, may not capture kinetic changes
Table 2: Enhanced formation of α-tocopheryl-quinone in medium and cells of IFN/LPS-treated C3H 10T1/2 cells. Confluent cultures of 
C3H 10T1/2 cells were pre-treated for seven days as indicated with either 10 µM α-tocopherol, 10 µM γ-tocopherol, or with 25 µL 
ethanol as a control. The cell culture media was then changed and cultures treated with either PBS (control) or IFN/LPS for seven 
days. To another group of dishes treated with either tocopherol for 7 days, 100 µM of the NO donor, SIN-1, was given to cells for 2 
hours. Samples of the media and cells were harvested and assayed for tocopherols and tocopherol oxidation products. Data are 
expressed as means ± SEM (n = 3).
Tocopherol Oxidant Tocopherol nmoles/106 cells 
(% of Control)
Tocopheryl Quinone nmoles/106 cells 
(% of Control)
5-Nitro-γ-Tocopherol 
nmoles/106 cells
Cells α-Tocopherol Control 1.32 ± 0.06 0.056 ± 0.002 -
α-Tocopherol IFN/LPS 1.42 ± 0.15 (+7.5%) 0.072 ± 0.005 (+28.6%)** -
α-Tocopherol SIN-1 1.38 ± 0.02 (+4.5%) 0.290 ± 0.008 (+418%)* -
γ-Tocopherol Control 1.49 ± 0.07 0.0067 ± 0.0008 nd
γ-Tocopherol IFN/LPS 2.50 ± 0.12 (+67.8%)* 0.0093 ± 0.0004 (+38.8%)** nd
γ-Tocopherol SIN-1 1.50 ± 0.05 (+0.7 %) 0.01 ± 0.005 (+49.2%)** nd
nmoles/dish nmoles/dish nmoles/dish
Media α-Tocopherol Control 47.8 ± 2.0 0.79 ± 0. 08 -
α-Tocopherol IFN/LPS 35.6 ± 1.1 (-25.5%)** 1.66 ± 0.06 (+110%)* -
α-Tocopherol SIN-1 1.9 ± 0.2 (-96%)* 34.0 ± 1.1 (+4,203%)* -
γ-Tocopherol Control 50.6 ± 1.4 0.30 ± 0.1 nd
γ-Tocopherol IFN/LPS 49.7 ± 1.3 (-1.8%) 0.28 ± 0.05 (-6.6%) nd
γ-Tocopherol SIN-1 1.6 ± 0.5 (-96.7%)* 1.50 ± 0.02 (+400%)* 11.9 ± 0.3*
Significantly different from its corresponding control value * p < 0.01; ** p < 0.05 nd = not detectedPage 7 of 12
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those reported by Gao, et al. [22], who did study kinetic
changes in cellular levels of tocopherols and their oxida-
tion products.
In contrast to the minimal effects of NO inhibition on the
loss of media tocopherol, intracellular concentrations of
both α- and γ-tocopherols are significantly increased
through the inhibition of NO synthesis by PBIT (Figure
2), suggesting that intracellular loss of tocopherol is
largely mediated by NO and/or its reaction products. NO-
mediated oxidation of key cellular targets was also
observed in these cells as evidenced by the formation of
the oxidative marker, 8-epi-prostaglandin F2α (Figures 3
and 4), and an increase in DNA strand breaks previously
described for IFN/LPS-treated 10T1/2 cells [44]. Interest-
ingly, it was previously observed that α-tocopherol alone
was ineffective at reducing either isoprostane formation or
DNA damage in IFN/LPS-stimulated cells, whereas the
presence of γ-tocopherol, β-tocopherol, or δ-tocopherol
alone reduced both types of oxidative damage to near con-
trol levels [44]. This is consistent with previous reports of
the comparative effects of tocopherols on NO2-mediated
damage in which a similar superiority of γ-tocopherol
over α-tocopherol was demonstrated in mammalian cells
[10,13,51]. The apparent inability of α-tocopherol and γ-
tocopherol to reduce isoprostane levels when both are
simultaneously present (Figure 3) is intriguing and
requires further study. It would appear from the data pre-
sented here that isoprostane formation is mediated by
NO, probably through its oxidation products, such as
NO2 and/or peroxynitrite. This is consistent with the
report of Marnett, et al. [52] who showed that deletion of
the iNOS gene significantly decreased F2 isoprostane for-
mation in vitro and in vivo in response to IFN/LPS treat-
ment. Ramsey et al [53] also demonstrated that
isoprostane formation induced by Chlamydia infection
was mediated through iNOS as well. The absence of
known markers of NO2 or peroxynitrite-mediated oxida-
tion of γ-tocopherol suggests either metabolism of the
products or that another oxidative intermediate may be
involved.
The types of oxidized tocopherols that are observed in cell
culture can indicate the nature of the oxidants that are
being generated. The absence of 5-nitro-γ-tocopherol in
cells treated with IFN/LPS (Table 2) suggests the absence
of nitrating species such as NO2 and peroxynitrite in the
aqueous phase of IFN/LPS treated cultures (or its metabo-
lism). In the case of SIN-1 treated cells, such a reaction
involving a nitrating species occurs to a significant extent
in the medium as evidenced by the formation of 5-nitro-
γ-tocopherol as the principal reaction product (Table 2),
consistent with the results described by Hoglen et al [54].
This suggests that the chemical oxidants generated by SIN-
1 are not representative of those produced and released
extracellularly by living cells stimulated with cytokines.
The data presented suggests a model in which extracellular
oxidants are generated by cells and that these oxidants
preferentially react with α-tocopherol to form α-tocophe-
rol oxidation products, principally α-tocopheryl-quinone.
Intracellularly, NO is generated, possibly as an anti-oxi-
dant [55,56], and any intracellular reactive oxygen or reac-
tive nitrogen species that form as a byproduct may be
detoxified by α-tocopherol and γ-tocopherol, respectively.
The absence of 5-nitro-γ-tocopherol and tocored in NO
producing cells suggests that peroxynitrite and NO2 may
not be formed intracellularly to a significant extent under
the conditions used in these experiments, despite its
potentially enhanced rate of formation from the oxida-
tion of NO in lipid phase environments [32]. Alterna-
tively it is possible that γ-tocopherol reaction products
may be further metabolized in cells, for example by a
nitratase enzyme [57] and are therefore not detected.
Increased γ-tocopheryl-quinone in cells treated with IFN/
LPS, but not in the media, confirms that γ-tocopherol
does indeed react with some oxidative specie(s) within
the cell, but not in the media. The generation of a product
distinct from that observed previously for the reaction of
γ-tocopherol with reactive nitrogen species, yet similar
chromatographically to tocored, was also observed and
suggests a possible unique reaction pathway. One likely
explanation is that low oxygen tension within the cells
does not favor the complete conversion of NO to NO2,
but rather forms the peroxynitrite radical intermediate,
which then reacts preferentially with γ-tocopherol to form
γ-tocopheryl quinone, as distinguished from the reaction
products seen for other oxidative nitrogen species [12].
Such a transient intermediate was observed previously
and postulated as a potential agent responsible for the
DNA damaging effects of NO in cells [58] in which oxida-
tion of NO was essential for cellular DNA damage, but
NO2 was determined not to be the agent responsible.
Conclusion
Cytokine-mediated inflammation is clearly an important
component in an organism's defense against infections,
however, it is a double-edged sword that may also play a
significant role in aging-related diseases. Optimizing
immune function while minimizing damage to normal
tissue may be key to reducing premature death from
aging-related diseases. The observed increase in cellular
tocopherol concentrations may be an important compo-
nent of the cell's response to infection and appears to be
specifically associated with mitigating damage resulting
from cellular NO synthesis. The role of tocopherols in the
process of cell-mediated immunity remains to be fully
delineated, however, studies elucidating the specific bio-
logical and chemical mechanisms of action for the toco-
pherols may ultimately lead to a better understanding ofPage 8 of 12
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diseases.
Methods
Chemicals
RRR-α-Tocopherol was purchased from Fluka Biochemika
(Ronkonkoma, NY). RRR γ-tocopherol was purchased
from Sigma Chemical Co. (St. Louis, MO). Tocol (3,4-
dihydro-2-methyl-2-(4,8,12-trimethyltridecyl)-6-chroma-
nol) was used as an internal standard in chromatography
and was a gift from Hoffmann-LaRoche (Basel, Switzer-
land). The concentrations of the tocopherol stock solu-
tions were determined by optical density readings at the
indicated wavelength with maximum absorption (λmax)
after diluting the stock solutions of the tocopherols to the
appropriate concentration with ethanol: α-tocopherol
(λmax= 292 nm; E1% = 75.8); γ-tocopherol (λmax= 298 nm;
E1% = 92.8)
Murine IFN-γ was obtained from Life Technologies, Inc.,
Grand Island, NY. Bacterial LPS (Escherichia coli, serotype
0127:B8) and 3-morpholino-sydnonimine (SIN-1) were
from Sigma Chemical Co., St. Louis, MO. S, S'-1,4-Phe-
nylene-bis(1,2-ethanedieyl)bis-thiourea dihydrobro-
mide (PBIT) and 8-epi-prostaglandin F2α standard were
purchased from Cayman Chemical Co., Ann Arbor, MI.
Spermine nonoate was obtained from Calbiochem, San
Diego, CA.
Cell culture
C3H 10T1/2 mouse fibroblasts (ATCC no. CCL 226), pas-
sages 8–15, were used for all experiments [59]. Unless
otherwise stated, cells were seeded in plastic tissue culture
dishes at a density of 4000 cells/ml in Eagle's basal
medium (BME) supplemented with 5% bovine calf serum
(Fisher Scientific, Hampton, NH.) and gentamycin sulfate
(25 µg/ml), and incubated at 37°C in a humidified
atmosphere of 5% CO2/95% air. At this seeding density,
confluent monolayers are normally formed by day 6 or 7
after plating. Cell numbers were determined as follows:
Cells were prepared by aspirating the media, washing the
cells with PBS and versene (0.2% ethylene diamine
tetraacetic acid in PBS), followed by trypsinization (0.4%
trypsin in PBS) in culture dishes for two minutes. Cells
were collected into sterile culture tubes followed by dilu-
tion with fresh media to inhibit trypsin and cell counts
performed using a Coulter counter (Coulter Electronics;
Hialeah, FL).
Mixed tocopherol treatment of C3H 10T1/2 cells
Treatments were done in triplicate. C3H 10T1/2 mouse
fibroblast cells were grown to confluence in 100 mm
dishes (N = 12) with 10 ml of culture medium. At conflu-
ence, a mixture of α- & γ-tocopherol (10 µM, final concen-
tration for each) in ethanol (50 µl) was added to each
dish. After seven days cell culture medium was changed
and cells were re-treated with tocopherol. At this time six
of the 12 dishes were also treated with IFN (10 ng/ml) &
LPS (1 µg/ml) to stimulate NO production. Three culture
plates that were treated with IFN/LPS and three that con-
tained only the mixture of tocopherols, were also treated
with 50 µl of 2 mM PBIT, a selective iNOS inhibitor, in
phosphate-buffered saline (PBS) yielding a final media
concentration of 10 µM PBIT. The other 6 dishes were
treated with either 50 µl PBS vehicle or PBIT (10 µM final
concentration). Seven days later, media nitrite and 8-epi-
prostaglandin F2α levels were measured according to the
methods described below in duplicate for each culture
dish. Media samples (1.0 ml for nitrite and 100 µl for 8-
epi-prostaglandin F2α analyses) from each culture dish
were removed and stored frozen in amber vials (12 × 32
mm, screw cap). Cell samples were prepared for analysis
by aspirating the media, washing the cells with PBS and
versene (10 µM), followed by trypsinization for 3 min-
utes. Using a rubber policeman, the dishes were scraped to
ensure that all the cells lifted off from the plate. The cells
were given fresh media (10 ml) to inhibit the trypsin, and
then pipetted into 15 ml centrifuge tubes. Cell numbers
were determined by taking 1 ml of the media and diluted
with 19 ml of 0.9% NaCl, and counted using a Coulter
counter. The remaining volume in tubes was centrifuged
for 15 min at 2500 rpm. After centrifuging, media was
again aspirated and PBS (2 ml) added to the cells and vor-
texed until they resuspended into the solution. Solution
was then pipetted into Kimax culture tubes with caps. To
assure the transfer of all cells, the centrifuge tube was
rinsed with PBS (2 ml), which was added into the culture
tubes. The cell suspension was then centrifuged for 15
min at 2500 rpm. After 15 min the supernatant was aspi-
rated and 1 ml PBS was added to cells, and all samples
were stored in a freezer @ -20°C. Tocopherol levels in
both the media and cells were determined as described
below.
Extraction of tocopherols
Media
At the time of extraction, media (1 ml) samples were
thawed and mixed with ethanol (1 ml), followed by addi-
tion of hexane (1 ml). The mixture was then vortexed for
one minute and centrifuged for five minutes at 2500 rpm.
The hexane phase containing the tocopherol extract was
transferred into an amber vial and dried under nitrogen
gas. This process was repeated three times for each media
sample. The dried extract was then dissolved into 200 µl
of 100% acetonitrile and analyzed by High Pressure Liq-
uid Chromatography (HPLC) as described below.
Cells
Cellular samples were defrosted and diluted with 300 µl
of pronase, then incubated in a water bath at 37°C. AfterPage 9 of 12
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of ethanol was added to each sample. Tocopherols from
the cells were extracted three times with 1 ml of hexane.
The sample extract was then transferred into an amber vial
and dried under nitrogen, as described previously for
media. The dried cell extract was then dissolved in 50 µl
of acetonitrile for analysis by HPLC.
Analytical methods
Tocopherols
Tocopherols were analyzed by HPLC according to the
method of Cooney et al [12]. A Waters Novapak C-18
reverse-phase (RP) column (10 × 4.6 mm; 5 µm particle
size) eluted with 100% acetonitrile was used at a flow rate
of 1.0 ml/min. The compounds were measured simulta-
neously at 270 nm and 295 nm using a Beckman HPLC
equipped with a dual wavelength diode array detector.
Tocopherol oxidation products
Altered products of γ- or α-tocopherols in cell cultures
were measured as follows. Cells were grown to confluence
in 100 mm dishes. After a media change, cells were treated
with either ethanol vehicle (25 µl), α-tocopherol, or γ-
tocopherol at a final concentration of 10 µM. One week
later at the time of media change cells were retreated with
tocopherols and within each tocopherol treatment group,
a subset of dishes was also treated with either PBS as a
control or IFN (10 ng/ml) and LPS (1 µg/ml). To a sepa-
rate group of cells treated with tocopherols only, the NO
donor, 3-morpholino-sydnonimine (SIN-1) dissolved in
PBS was added to the cell culture medium (final concen-
tration – 100 µM) seven days after the final tocopherol
treatment and media change. After a SIN-1 treatment
period of two hours, media and cellular samples from all
treatment groups (including IFN/LPS-treated and toco-
pherols only) were collected to determine the presence of
altered tocopherol products. Tocopherol extraction with
hexane was performed and altered tocopherol products in
these fractions were then analyzed by reverse-phase HPLC
as described above. Three independent experiments were
performed to measure the effects of the various forms of
tocopherol + IFN/LPS for each tocopherol and treatment
group.
8-epi-prostaglandin F2a
As a measure of cellular oxidation caused by IFN/LPS
treatment, media levels of 8-epi-prostaglandin F2α were
measured in 100 µl samples of cell culture media using an
enzyme immunoassay kit (#516351) from Cayman
Chemical Co., Ann Arbor, MI according to the directions
of the manufacturer. A standard curve utilizing authentic
8-epi-prostaglandin F2α standard was generated for each
assay and values for 8-epi-prostaglandin F2α are reported
as pg/ml of media.
Nitrite analysis
The concentration of nitrite in culture media was deter-
mined by a modification of the Saltzman assay [60].
Briefly, 100 µl aliquots of media were mixed with 900 µl
of absorbing reagent (0.5% sulfanilic acid, 0.002% N-1-
naphtylethylenediamine dihydrochloride, 14% glacial
acetic acid) and incubated at room temperature for 30
min. Light absorbance (546 nm) of the solution was then
measured in a Shimadzu UV160U spectrophotometer and
compared to standard solutions of sodium nitrite dis-
solved in distilled water and added to the absorbing rea-
gent. The detection of nitrite with this assay was linear
over the range of 0.2 µM to at least 30 µM. All experimen-
tal values were corrected for the nitrite content of time-
matched culture media and incubation buffers devoid of
cells.
Statistical analysis
Treatment groups were analyzed by One Way Analysis of
Variance (ANOVA) utilizing GraphPad Software Inc. (San
Diego, CA) InStat program. A Dunnett multiple compari-
sons test was used to determine significant differences
between treatment groups and their respective control.
Deviations from normality in standard deviations were
tested by the method of Bartlett. In those cases where
there were significant differences in standard deviations
between groups, values were log-transformed prior to sta-
tistical analysis. Comparisons between control and single
treatment or between media vs cellular mean values were
analyzed by a two-tailed unpaired student t-test.
Abreviations
IFN – interferon-γ
LPS – bacterial lipopolysaccharide
NO – nitric oxide
nd – not detected
NO2 – nitrogen dioxide radical
PBIT – S, S'-1,4-Phenylene-bis(1,2-ethanedieyl)bis-thiourea
dihydrobromide
iNOS – inducible nitric oxide synthase
PBS – phosphate-buffered saline
HPLC – high pressure liquid chromatography
SIN-1 – 3-morpholino-sydnonimine
SEM – standard error of the meanPage 10 of 12
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